ANGION BIOMEDICA

Angion Biomedica is a clinical-stage organ restoration biopharmaceutical company focused on renal disease. Its investigational drug BB3 is entering phase 3 for delayed graft function following kidney transplant and phase 2 for acute kidney injury following open-heart surgery using cardiopulmonary bypass.

ANGION BIOMEDICA

Social Links:

Industry:

Biopharma Biotechnology Medical

Founded:

1998-01-01

Address:

Uniondale, New York, United States

Country:

United States

Website Url:

http://www.angion.com

Total Employee:

101+

Status:

Active

Contact:

5168691359

Email Addresses:

[email protected]

Total Funding:

84.27 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics

Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Employees Featured

jay-venkatesan_image

Jay Venkatesan
Jay Venkatesan President, Chief Executive Officer and Director @ Angion Biomedica
President, Chief Executive Officer and Director
2018-05-01

itzhak-goldberg_image

Itzhak Goldberg
Itzhak Goldberg Executive Chairman and Chief Scientific Officer @ Angion Biomedica
Executive Chairman and Chief Scientific Officer

Founder

itzhak-goldberg_image

Itzhak Goldberg

Stock Details

Company's stock symbol is NASDAQ:ANGN

Investors List

vifor-pharma_image

Official Site Inspections

http://www.angion.com Semrush global rank: 2.67 M Semrush visits lastest month: 6.29 K

Host Informations
Whois Informations

Loading ...